postmenopausal

1.Food and Drug Administration (FDA) has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.

苯卓昔芬是一种选择性雌激素受体调节剂，为预防后骨质疏松症药。

2.Hormone therapy and enous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

后女性中激素疗法与静脉血栓栓塞相关性——雌激素给药途径与孕激素对其影响（ESTHER研究）

3.Title：Hormone therapy and enous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

后女性中激素疗法与静脉血栓栓塞相关性——雌激素给药途径与孕激素对其影响（ESTHER研究）